Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 63187-259

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 63187-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Rabeprazole Sodium Delayed Release Tablets 1)

FDA Label Image

Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)

Figure 2 (Rabeprazole Sodium Delayed Release Tablets 2)
This appears to be a table showing the results of a study on three groups of participants. The first group ("PLACEBO") had 68 participants, the second group ("RAB 10mg") had 64 participants, and the third group ("RAB20mg") had 67 participants. The numbers at the bottom of the table may represent study days. The table appears to show heartburn scores, with 0 indicating no heartburn and 4 indicating very severe heartburn.*
FDA Label Image

Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)

Figure 3 (Rabeprazole Sodium Delayed Release Tablets 3)
This appears to be a summary of a pharmaceutical study comparing the effects of a placebo against two doses of a drug called RAB (10mg and 20mg). The study involved 68 participants in the placebo group, 64 participants in the RAB 10mg group, and 67 participants in the RAB 20mg group. However, without more context or information, it is difficult to determine the exact purpose or findings of the study.*
FDA Label Image

Figure 4 (Rabeprazole Sodium Delayed Release Tablets 4)

FDA Label Image

Figure 5 (Rabeprazole Sodium Delayed Release Tablets 5)

FDA Label Image

63187-259-30 (Rabeprazole Sodium Delayed Release Tablets 6)

63187-259-30 (Rabeprazole Sodium Delayed Release Tablets 6)
This is a description of Rabeprazole Sodium 20mg RX tablets distributed by Lannett Company, Inc. The package includes 30 delayed-release, blue-colored tablets with "KU" imprint on one side and '7" on the other. The medication guide should be handed over to each patient. The tablets are stored at a temperature of 25°C (77°F) and away from children's reach. Each DR tablet contains 20mg of rabeprazole sodium. Different product IDs are used for this drug, including PR025930, NOC 6318725630, NOC 63187-25.0, and NOC 6318725030. The expiration date and lot number of this medication are both 00000. The GTIN of this product is 0363167259303.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.